Herceptin®: increasing survival in metastatic breast cancer-Reference-Cited by-同舟云学术

Herceptin®: increasing survival in metastatic breast cancer

Published:2000-03 Issue: Volume:4 Page:24-29
ISSN:1462-3889
Container-title:European Journal of Oncology Nursing
language:en
Short-container-title:European Journal of Oncology Nursing

Author:

Slamon Dennis

Publisher

Elsevier BV

Subject

Oncology(nursing),General Medicine

Reference44 articles.

1. Growth factors and cancer;Aaronson;Science,1991

2. Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice;Aboud-Pirak;Journal of the National Cancer Institute,1988

3. The product of the c- erb B-2 gene: a 185-kilodalton glycoprotein with tyrosine activity;Akiyama;Science,1986

4. Phase II study of weekly intravenous recombinant humanized anti-p185HER2monoclonal antibody in patients with HER2/neu -overexpressing metastatic breast cancer;Baselga;Journal of Clinical Oncology,1996

5. Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts;Baselga;Cancer Research,1998

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ethical Concerns of the Veterinarian in Relation to Experimental Animals and In Vivo Research;Animals;2023-07-31

2. Confirmatory prediction-driven RCTs in comparative effectiveness settings for cancer treatment;British Journal of Cancer;2023-01-23

3. Regulation of Signaling from the Epidermal Growth Factor Family;J PHYS CHEM B;2022

4. Engineering nanosystems to overcome barriers to cancer diagnosis and treatment;Advanced Drug Delivery Reviews;2022-10

5. Regulation of Signaling from the Epidermal Growth Factor Family;The Journal of Physical Chemistry B;2022-08-31